Compare Cigna Corp (CI) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Illumina, Inc. — how do they compare? Cigna Corp trades at $302.09 (market cap $80.55B), while Illumina, Inc. trades at $191.2 (market cap $28.75B). The key difference: Cigna Corp is far larger — about 2.8× Illumina, Inc.'s market cap, and Cigna Corp pays a 2.05% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| CI | ILMN | |
|---|---|---|
Market Cap | $80.55B | $28.75B |
Sector | Health | Health |
52-Week High | $311.00 | $194.33 |
52-Week Low | $244.41 | $91.00 |
Enterprise Value | $103.65B | $30.14B |
Dividend Yield | 2.05% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
